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Summary
Androgens and estrogens are transported bound to
the sex hormone binding globulin (SHBG). SHBG is
believed to keep sex steroids inactive and to control
the amount of free hormones that enter cells by pas-
sive diffusion. Contrary to the free hormone hypothe-
sis, we demonstrate that megalin, an endocytic recep-
tor in reproductive tissues, acts as a pathway for
cellular uptake of biologically active androgens and
estrogens bound to SHBG. In line with this function,
lack of receptor expression in megalin knockout mice
results in impaired descent of the testes into the scro-
tum in males and blockade of vagina opening in fe-
males. Both processes are critically dependent on
sex-steroid signaling, and similar defects are seen in
animals treated with androgen- or estrogen-receptor
antagonists. Thus, our findings uncover the existence
of endocytic pathways for protein bound androgens
and estrogens and their crucial role in development
of the reproductive organs.
Introduction
Steroid hormones are lipids with important regulatory
functions. They exert main regulatory activities by en-
tering target cells and associating with nuclear hor-
mone receptors that, in turn, act as transcriptional acti-*Correspondence: an@biokemi.au.dk (A.N.); willnow@mdc-berlin.de
(T.E.W.)
6 These authors contributed equally to the study.vators of steroid-responsive genes. Rather than being
transported by lipoproteins like cholesterol, these cho-
lesterol derivatives are bound by specific carrier pro-
teins in the extracellular space. Such carriers include
the sex hormone binding globulin (SHBG) and the corti-
costeroid binding globulin (CBG), transporters for sex
steroids and corticosteroids, respectively (Hammond
and Bocchinfuso, 1995; Scrocchi et al., 1993). Accord-
ing to the free hormone hypothesis, only free steroids
are biologically relevant, whereas carrier bound ste-
roids are inactive because they are blocked from enter-
ing target cells (Mendel, 1989).
Similar to steroid hormones, vitamins A and D are
also transported by plasma carriers. Previously, these
lipophilic metabolites were also believed to solely enter
cells by free diffusion. However, we recently demon-
strated the existence of endocytic pathways for tissue-
specific uptake of the complexed vitamins. Megalin is
a member of the LDL receptor gene family and the first
confirmed endocytic receptor for carrier bound vita-
mins A and D. The receptor is expressed in epithelial
cells of the renal proximal tubules where it binds com-
plexes of 25-OH vitamin D3 with the vitamin D binding
protein (DBP) and vitamin A with the retinol binding pro-
tein (RBP). Following internalization, the carriers are de-
graded in lysosomes while the lipids are released into
the cytosol for further metabolism (Christensen et al.,
1999; Nykjaer et al., 1999). Endocytosis of vitamin/car-
rier complexes in the proximal tubules prevents urinary
loss of vitamins filtered through the glomerulus, and it
delivers the precursor 25-OH vitamin D3 to tubular cells
for conversion into 1,25-(OH)2 vitamin D3, a potent reg-
ulator of calcium homeostasis. Loss of megalin expres-
sion in knockout mice results in vitamin D deficiency
and in bone-calcification defects, underscoring the im-
portance of this endocytic pathway for vitamin D action
in vivo (Nykjaer et al., 1999). Today, the significance of
endocytosis of lipid/carrier complexes for tissue-spe-
cific delivery of vitamins A and D is well appreciated.
However, this mode of lipid uptake is considered
unique to the renal vitamin metabolism and perhaps not
relevant for uptake of other carrier bound lipids such
as steroid hormones.
Besides in the renal proximal tubules, megalin is ex-
pressed in a number of steroid-responsive tissues, in
particular in the male and female reproductive organs
(epididymis, prostate, ovaries, uterus) (Zheng et al.,
1994). This observation raises the intriguing possibility
that the role of megalin may not be restricted to endo-
cytosis of vitamins but may extend to the cellular up-
take of steroid hormones such as androgens and estro-
gens. Previous experimental evidence suggested the
existence of cell-surface binding sites for SHBG in ste-
roid-responsive tissues including uterus, epididymis,
and prostate. Their identity and their significance for
sex-steroid activity remained controversial (Krupenko et
al., 1994; Rosner et al., 1999; Turner and Roddy, 1990).
Here we investigated the possible role of megalin in
the cellular delivery of sex steroids and the conse-
quences of receptor deficiency for androgen and estro-
Cell
752gen action in vivo. We demonstrate that, in cultured
cells, megalin internalizes complexes of sex steroids
bound to SHBG. Following internalization, the carrier is
degraded in lysosomes while the steroids are released
to induce steroid-responsive genes. Lack of receptor
expression in knockout mice results in testicular malde-
scent and vaginal obstruction, two phenotypes consis-
tent with insensitivity of megalin-deficient tissues to an-
drogen and estrogen signals.
Results
Androgen and estrogen binding proteins are present in
most body fluids, the most common being SHBG, a ho-
modimeric protein produced in the liver and secreted
into the circulation in humans (Hammond and Bocchin-
fuso, 1995). In rodents, this protein is known as the an-
drogen binding protein (ABP) that is mainly produced
by the fetal liver (Sullivan et al., 1991) and by Sertoli
cells of the adult testes (Feldman et al., 1981). Because
megalin is expressed in sex-steroid target tissues, we
tested involvement of this receptor in the cellular up-
take of steroid/SHBG complexes.
To do so, we developed a eukaryotic expression sys-
tem to produce recombinant SHBG that closely resem-
bles the native human protein in terms of steroid bind-
ing activity and ability to bind to membranes from
steroidogenic tissues (Hilpert et al., 2001). Recombi-
nant SHBG bound to purified megalin in vitro, as shown
by surface plasmon resonance analysis (Figure 1A). The
affinity of binding (Kd = 200 nM) was similar to that of
DBP to megalin (Nykjaer et al., 1999). No SHBG binding
was seen when the receptor was reduced, document-
ing specificity of the interaction (Figure 1A).
Brown Norway rat choriocarcinoma (BN16) cells ex-
press megalin but no related endocytic receptors (see
Figure S1A in the Supplemental Data available with this
article online). They are commonly used as a model
system to evaluate cellular megalin activity. When
SHBG was labeled with iodine and added to BN16
cells, efficient uptake and degradation of the protein
was observed (Figure 1B, filled columns). Cellular ca-
tabolism of [125I]SHBG was blocked by the addition of
the receptor-associated protein (RAP), an antagonist of
ligand binding to megalin (Nykjaer et al., 1999) (Figure
1B), and by leupeptin and pepstatin, inhibitors of lyso-
somal proteases (data not shown). Megalin-mediated
uptake of SHBG was not affected by the addition of
testosterone to the culture medium (Figure 1B, open
columns). RAP-inhibitable uptake and degradation was
also seen for 125I-labeled rat and murine ABP (Figure
1B, striped and hatched columns, respectively).
To explore the effect of this endocytic pathway for
SHBG/ABP on the cellular metabolism of testosterone,
we determined uptake of [3H]testosterone in BN16 cells
in the presence of unlabeled SHBG. After 5 hr, approxi-
mately 11% of the tracer was associated with the cells,
a process that was blocked by RAP (Figure 1C, filled
columns). Megalin-mediated uptake of testosterone was
critically dependent on the amount of SHBG present in
the culture medium as shown by varying the molar ratio
of carrier and testosterone (Figure 1C, open columns).
At a ratio of carrier to steroid of 5:1 when 95% of the
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wteroid is bound to SHBG (Figure S2), cell association
f [3H]testosterone was absolutely dependent on meg-
lin activity as evidenced by RAP inhibitability. At a mo-
ar ratio of 1:10 when 98% of [3H]testosterone is free
Figure S2), cell association was independent of mega-
in and insensitive to RAP. At a molar ratio of 1:1 when
0% of testosterone is complexed (Figure S2), uptake
as partially dependent on megalin activity (Figure 1C).
n the human circulation (adult males), the ratio of
HBG to testosterone is approximately 3:1 (Turner et
l., 1984). SHBG bound testosterone was unable to en-
er cells when megalin was blocked by RAP and instead
ccumulated in the medium of the cells (Figure 1D).
To confirm that SHBG and androgens are taken up in
complex (and not independently of each other) by
ells, we incubated BN16 cells with preformed com-
lexes of dihydrotestosterone (DHT)/SHBG labeled
ither at the steroid ([3H]DHT; Figure 1E, filled bars) or
he carrier moiety ([125I]SHBG; Figure 1E, open bars).
imilar amounts of both tracers were detected in the
ell fraction in a RAP-sensitive manner. The same find-
ng was seen for testosterone/SHBG complexes (Figure
E, striped and hatched columns). Uptake of androgen/
HBG complexes was also blocked by anti-megalin
ntiserum and by purified SHBG, confirming that the
HBG/ABP receptor megalin is responsible for steroid
ptake (Figure S3). Megalin was equally important for
he cellular uptake of androgens and estrogens, as
emonstrated by identical RAP-sensitive uptake mech-
nisms for [3H]DHT/SHBG and [3H]17β-estradiol ([3H]E2)/
HBG complexes in BN16 cells (Figure 1F). Remarka-
ly, keratinocytes that do not express megalin were un-
ble to internalize significant amounts of complexed
HT or E2 (Figure 1F). The different abilities of BN16
ells and keratinocytes to accumulate bound steroids
ere not due to differences in nuclear-hormone-recep-
or profile because neither cell type expressed detect-
ble levels of androgen or estrogen receptors (Figure S1B).
We confirmed the intracellular delivery of bound sex
teroids through megalin-mediated endocytosis using
onfocal fluorescence microscopy. When FITC-labeled
HT was complexed with SHBG and added to BN16
ells, uptake and intracellular colocalization of FITC-
HT and SHBG was shown (Figure 2A). Megalin was
ndispensable for this process, as cellular uptake of
omplexed FITC-DHT was blocked completely by RAP
Figure 2A). Complexed steroids internalized via mega-
in were fully active in inducing an androgen-responsive
uciferase reporter construct transfected into BN16
ells. In fact, 1 nM of SHBG bound DHT was at least as
ctive in inducing the reporter as unphysiologically high
quimolar amounts of free steroids added to the culture
edium (Figure 2B). SHBG alone had no effect (Figure
B). RAP inhibited gene induction by SHBG-complexed
ut not by free DHT (Figure 2C), indicating the need for
he megalin pathways for signaling of steroid/carrier
omplexes.
Taken together, our data in BN16 cells demonstrated
hat, under physiological conditions where 98%–99.5%
f sex steroids are present in protein bound form (Dunn
t al., 1981), endocytosis is quantitatively more relevant
or tissue delivery of biologically active steroid hor-
ones than free diffusion. To test this hypothesis in vivo,
e evaluated the consequences of megalin deficiency
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753Figure 1. Cellular Metabolism of SHBG and SHBG/Steroid Complexes
All data represent mean values ± standard error of the mean (SEM).
(A) Surface plasmon resonance analysis of 500 nM recombinant SHBG binding to native but not reduced megalin immobilized on the sensor-
chip surface.
(B) Triplicate monolayers of BN16 cells were incubated with 1 nM recombinant 125I-labeled SHBG (with or without 1 nM testosterone),
recombinant 125I-labeled rat ABP, or recombinant 125I-labeled mouse ABP in the presence (+) or absence (−) of the receptor-associated protein
(RAP). The amount of iodinated carrier degraded after 5 hr was determined and indicated as % of total tracer added.
(C and D) BN16 cells were incubated with 1 nM [3H]testosterone in the presence of 500 nM recombinant SHBG (filled columns) or with 1 nM
[3H]testosterone in the presence of 100 nM unlabeled testosterone and the indicated concentrations of SHBG (open columns). After 5 hr, the
amount of [3H]testosterone associated with the cells (C) or residing in the medium (D) in the presence or absence of RAP was determined.
(E) BN16 cells were incubated with 1 nM of the indicated preformed SHBG/androgen complexes for 5 hr in the presence or absence of RAP,
and the amount of cell-associated tracer was determined thereafter.
(F) BN16 cells and human keratinocytes were incubated with 1 nM [3H]DHT (closed columns) or 1 nM [3H]17β-estradiol (E2) (open columns)
in the presence of 10 nM recombinant SHBG for 5 hr, and the amount of tracer associated with the cells was determined in the presence or
absence of RAP.
Cell
754Figure 2. Uptake and Signaling by SHBG/DHT Complexes in BN16 Cells
(A) Cells were incubated with 800 nM preformed complexes of FITC-DHT/SHBG in the presence or absence of RAP, and the subcellular
localization of FITC-DHT and SHBG (anti-SHBG antibody, followed by secondary Alexa 660-labeled IgG) was detected by confocal immunoflu-
orescence microscopy.
(B) Induction of an androgen-responsive luciferase gene was evaluated in BN16 cells treated with 1 nM free (DHT) or 1 nM complexed DHT
(DHT/SHBG) or with SHBG-conditioned medium only (SHBG).
(C) Luciferase gene induction by 1 nM DHT/SHBG or 1 nM free DHT in the absence or presence of 5 M RAP. Data in (B) and (C) represent
mean values ± SEM.on the action of sex steroids using the megalin knock-
out mouse model (Willnow et al., 1996). Most megalin-
deficient (megalin−/−) mice die perinatally from a defect
in forebrain development. However, approximately 5%
of megalin−/− animals survive the perinatal period, ena-
bling analysis of megalin deficiency in the adult organ-
ism (Nykjaer et al., 1999). In the following studies, meg-
alin knockout mice on a hybrid (129/SvEmcTer ×
C57BL/6N) and on an inbred (CD1) genetic background
were used. Both strains gave identical results. Thus,
megalin−/− females were characterized by a closure of
the vagina opening, a feature not seen in control litter-
mates (Figure 3A). As a consequence of the closed va-
gina cavity, uterine fluid accumulated in the uterus of
the knockouts, grossly inflating the organ (Figure 3B).
In wild-types, megalin is expressed on the luminal sur-
face of the uterine epithelium (Figure 3C; Figure S4),
with onset of expression at puberty. Interestingly, meg-
alin expression in the endometrium is tightly regulated
during estrus cycle, with highest levels of expression in
metestrus II and diestrus (Figure 3C). Loss of receptor
expression in knockouts did not alter the overall tissue
architecture that was composed of a mesenchymal
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atroma covered by a layer of epithelial cells. However,
he knockout tissue appeared thinner compared to that
f controls, likely due to the accrual of mucoid secre-
ion that massively stretched the uterus (Figure 3D).
Female rodents are born with a closed vagina cavity
hat opens up 4 to 5 weeks after birth due to estrogen-
nduced apoptotic processes (Rodriguez et al., 1997).
pplication of anti-estrogens blocks this process and
elays vagina opening, a defect that is used as a bio-
ndicator of anti-estrogen action (Ashby et al., 2002;
hadwick et al., 1988). Thus, the phenotype in the meg-
lin-deficient mice may be indicative of impaired estro-
en signaling during the postnatal development of the
emale genitalia. Consistent with this hypothesis, the
istological appearance of vaginal tissues in megalin−/−
dult animals was similar to that of wild-type juvenile
ice before puberty (Figures 3E–3K). Adult wild-type
ice presented with a clearly defined vagina opening
Figure 3E) surrounded by a thick columnar epithelium
Figure 3F). In contrast, in adult megalin-deficient mice,
he vagina opening was closed by a septum composed
f an epithelial cell layer followed by connective tissue
nd skin (Figures 3G and 3H). Similar features were
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755Figure 3. Female Reproductive Tracts in Wild-Type and Megalin-Deficient Mice
(A) Inspection of the external genitalia of female mice, with closure of the vagina cavity (arrows) in megalin-deficient (−/−) but not wild-type
animals (+/+).
(B) Uteri of wild-type and megalin−/− mice.
(C) Expression of megalin (arrow) on the luminal surface of the uterine epithelium of wild-type mice during estrus cycle.
(D) Hematoxylin and eosin (H&E) stained sections of wild-type and megalin-deficient uteri in diestrus, indicating epithelial (ep) and stromal
tissues (st), as well as mucoid accrual in the uterine lumen of the knockouts (asterisk).
(E–K) H&E-stained sections from vaginal tissues of 12-week-old wild-type (E and F) and megalin-deficient (G and H) animals in diestrus or
from 2-week-old wild-type mice (I and K). (E), (G), and (I) depict cross-sections of the vagina opening, where E indicates the exterior of the
genitalia. (F), (H), and (K) are higher magnifications of vaginal tissue sections. ct, connective tissue; ep, vaginal epithelium; sk, skin; st, stroma.
(C, E, G, I, ×40; D, F, H, K, ×100.)seen in wild-type juvenile mice prior to sexual matura-
tion (Figures 3I and 3K). E2 levels in megalin−/− females
were similar to the levels in wild-type littermates (Table
1), indicating that estrogen insensitivity rather than lackTable 1. Steroid-Hormone Concentrations in Adult Plasma or E14.5 Embryonic Tissue Extracts of Wild-Type and megalin Knockout Mice,
± Standard Error of the Mean
+/+ n −/− n
Adult Plasma
Testosterone (pg/ml) 6154.0 ± 2355 12 6440.0 ± 2442 6
DHT (pg/ml) 808.0 ± 245 12 978.0 ± 265 6
E2 (pg/ml) 41.5 ± 2.3 10 44.9 ± 10.2 6
E14.5 Embryo
Testosterone (ng/g) 454.0 ± 46 19 800.0 ± 156* 10
DHT (ng/g) 388.0 ± 26 28 496.0 ± 55** 14
E2 (ng/g) 125.0 ± 43 11 102.0 ± 30 6
Testosterone and DHT levels were determined in males; E2 levels were determined in females. n, number of animals. *p < 0.05, Mann-Whitney
U test; **p < 0.05, Student’s t test.
alin-deficient mice also lack proper androgen signalingof estrogens was the underlying cause of this phe-
notype.
As well as suffering from estrogen insensitivity, meg-
Cell
756during development of the male reproductive organs.
In all male receptor-deficient animals analyzed (n = 21),
the left testis had not descended into the scrotum but
was located in the body cavity (cryptorchidism). As a
consequence of the unilateral testicular maldescent,
the cryptorchid (left) testis was poorly developed and
severely retarded in size (Figure 4B). Other aspects of
the urogenitalia such as the contralateral testis, the
epididymis, or the seminal vesicles exhibited normal
appearance (Figure 4B). In histological sections, the
cryptorchid testis was characterized by degenerated
germinal epithelia of the seminiferous tubules and by
the absence of germ cells (Figure 4G). The correspond-
ing epididymis was devoid of sperm (Figure 4H). In con-
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sFigure 4. Male Urogenital Tracts of Adult Wild-Type and Megalin-
Deficient Mice
(A and B) Inspections of the urogenital tracts of wild-type (A) and
megalin-deficient adult mice (B). Note the reduced size of the cryp-
torchid testis in the megalin−/− animal (arrow).
(C–H) H&E-stained sections from wild-type testis (C) and corpus
epididymis (D) compared to sections from descended (E) and non-
descended (G) testis or descended (F) and nondescended (H) cor-
pus epididymis of megalin−/− mice. Arrowheads indicate sperm in
the lumen of wild-type (D) and descended megalin−/− epididymi. bl,
bladder; ep, epididymis; sem, seminal vesicles; te, testis. (C–H, ×200.)
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arast, the descended testis of knockout mice exhibited
ell-differentiated germinal epithelia (Figure 4E) and
roduced spermatozoa that filled the lumen of the epi-
idymal ducts (Figure 4F), identical to the situation in
ild-type controls (Figures 4C and 4D). Thus, megalin
ctivity is not required for normal development and
tructural integrity of the male reproductive organs but
s essential to control descent of the testes. Histologi-
al abnormalities in the cryptorchid testis are likely sec-
ndary to its exposure to a higher temperature in the
bdomen.
Descent of the testes proceeds in two distinct steps.
n early mouse embryos, the testes migrate from a posi-
ion near the lower pole of the kidney to a region close
o the bladder (transabdominal phase), while, after birth,
he testes move further into the scrotum (inguinoscrotal
hase) (Heyns and Hutson, 1995). Defects in either
hase of testicular descent cause cryptorchidism (Top-
ari and Kaleva, 1999). To identify what phase of the
esticular descent was affected in megalin-deficient
ice, we analyzed the urogenital tract in E18.5 (data
ot shown) and newborn animals (Figure 5). In wild-type
eonates, the testes were located near the bladder
eck, consistent with completion of the transabdominal
escent (Figure 5A). In contrast, in the megalin−/− new-
orns, both testes were positioned halfway between
he kidney and the bladder (Figure 5A). Remarkably, an
xtensive ligament-like structure was apparent that
ixed the gonads to the dorsal abdominal wall (arrow,
igure 5A). This structure is the cranial suspensory liga-
ent (CSL), one of two tissues that control the position
f the gonads in both sexes. The second tissue is the
ubernaculum, a structure that attaches to the caudal
nd of the gonads. Both ligaments are present in male
nd female embryos around midgestation. In females,
he CSL persists and holds the ovaries in a position
lose to the kidney. In males, the primordium of the CSL
egresses during development, and the gubernaculum
tracks” the testes toward the lower abdomen (Heyns
nd Hutson, 1995). Histological examination of the uro-
enital tract in wild-type newborn males highlights this
oncept (Figure 5B). The testes and epididymi are lo-
ated close to the bladder. The gubernaculum (com-
osed of gubernacular cord and gubernacular bulb) is
ully developed but the CSL is absent. In megalin-defi-
ient newborns, both gubernaculum and CSL are still
resent at the lower and upper pole of the gonads, re-
pectively (Figure 5C), with the CSL tethering the testes
nd epididymi to the abdominal body wall dorsal to the
idney (Figure 5D).
The descent of the testes is tightly regulated by an-
rogens (Husmann and McPhaul, 1991; Spencer et al.,
991). Among other effects, androgens induce regres-
ion of the primordium of the CSL in male embryos
tarting around E14.5, enabling free movement of the
onads toward the lower abdomen (Emmen et al., 1998;
ee and Hutson, 1999). In male mice with an androgen
eceptor (AR) gene defect (Hutson, 1986; Zimmermann
t al., 1999) or in rodent embryos treated in utero with
he AR antagonist flutamide (van der Schoot and Elger,
992), lack of fetal androgen signaling results in abnor-
al persistence of the CSL and in testicular malde-
cent. To confirm that megalin−/− male embryos also
uffer from impaired induction of CSL regression, we
Endocytic Pathways for Sex Steroids
757Figure 5. Urogenital Tracts of Male Neonates
(A) Urogenital tracts from wild-type and megalin-deficient newborn
mice. The arrowhead highlights the cranial suspensory ligament
(CSL) attached to the gonads in megalin−/− animals.
(B and C) Histological sections of the urogenital tracts of wild-type
(B) and megalin−/− neonates (C) (magnification ×25). The arrow in
(C) indicates the CSL fixing the gonads of megalin−/− animals to the
dorsal abdominal body wall.
(D) Higher magnification (×100) of the CSL in megalin−/− neonates.
bl, bladder; ep, epididymis; gb, gubernacular bulb; gc, gubernacu-
lar cord, ki, kidney; te, testis.analyzed the appearance of this ligament in wild-type
and knockout embryos. In wild-type E14.5 male em-
bryos, the CSL was still apparent as a thin tissue strand
that connected the gonads with the craniolateral sur-
face of the dorsal abdominal wall (Figure 6A). At this
time in development, megalin was expressed in the
mesonephric tubules of the gonads in close proximity
to the primordium of the CSL (Figure 6B). In receptor-
deficient E14.5 males, the CSL represented a thick
cord-like structure (Figure 6C) that shared striking re-
semblance with the CSL of wild-type female embryosFigure 6. Histology and Megalin Expression Pattern of E14.5 Uro-
genital Tracts
(A and B) Histological sections from wild-type male embryos sub-
jected to staining with H&E (A) or immunodetection of megalin (B).
Arrowheads in (B) indicate expression of megalin in the mesoneph-
ric tubules of the gonads (highlighted in inset). The arrow marks
the primordium of the CSL.
(C) H&E section of the urogenital tract of a male E14.5 megalin−/−
embryo.
(D) Section of the urogenital tract of a wild-type female E14.5
embryo. ad, adrenal gland; gd, gonads; ki, kidney. (A, C, D, ×40;
B, ×200).(Figure 6D). At earlier time points in development, no
obvious difference in the histological appearance of
wild-type and megalin−/− urogenital tissues was seen
(data not shown). Failure of regression of the CSL in
megalin-deficient male embryos was not due to a de-
fect in androgen production. Rather, the amount of cir-
culating testosterone and DHT was increased 2-fold
compared to control littermates (Table 1). Also, no dis-
cernable difference was seen in androgen levels in
adult megalin−/− males compared to controls (Table 1).
Presently, genes regulated by steroid hormones dur-
ing induced regression of the CSL are unknown. To
identify such genes and to evaluate their expression
levels in megalin-deficient mice, we performed global
gene-expression profiling on gonads from E14.5 mega-
lin+/+ and megalin−/− embryos. A total of six genes were
Cell
758marked as significantly changed according to the strin-
gent preset quality criteria (expression levels > 200, fold
change > 2) (Table S1, upper panel). Five out of the six
genes indicated defects in testis development (Tex12,
Morc, Stk25) as well as impairment in steroid-hormone
signaling (Ramp2, Mpo) in the knockouts. Remarkably,
Ramp2, a gene induced by sex steroids, was reduced
in the knockouts, whereas Mpo, a sex-steroid-repressed
gene, was induced. We also evaluated the expression
profiles with respect to 20 candidate genes known to
be upregulated in the adult mouse epididymis upon an-
drogen removal (Chauvin and Griswold, 2004) (Table
S1, lower panel). Intriguingly, megalin-deficient em-
bryos exhibited significantly increased expression of
Igfbp5, a gene that is induced upon androgen removal
in mice (Chauvin and Griswold, 2004) and that is upreg-
ulated in patients with androgen insensitivity syndrome
(Diesing et al., 2003).
Finally, we confirmed steroid insensitivity of megalin-
deficient embryonic tissues using exogenous androgen
application. When pregnant rats are injected with high
doses of androgens, excessive androgen signaling
causes aberrant regression of the CSL in the female
embryos (Emmen et al., 1998), a phenomenon that we
confirmed in the mouse model (Figure 7). Normally, the
ovaries of wild-type and megalin-deficient female E18.5
embryos are positioned laterally to the lower kidney
pole (Figures 7A and 7B), with the CSL fixing the go-
nads to the dorsal body wall (Figures 7E and 7F). When
treated with exogenous DHT in utero, wild-type females
induced regression of the CSL (Figure 7G), displacing
the ovaries from the lower kidney pole (Figure 7C). In
contrast, megalin-deficient females responded poorly
to DHT injection, with only partially displaced ovaries
(Figure 7D) and clearly visible CSL (Figure 7H). In un-
treated wild-type male embryos, the gonads are lo-
cated near the bladder in wild-types (Figures 7I and 7N)
but tethered through aberrant CSL to the body wall dor-
sal to the kidney in knockouts (Figures 7K and 7O). Ap-
plication of exogenous DHT did not affect positioning
of the gonads in wild-type males because endogenous
androgen signaling is normal in these animals (Figures
7L and 7P). Similar to the females, megalin-deficient
male embryos did not respond properly to exogenous
androgen application and still exhibited abnormal per-
sistence of the CSL (Figure 7Q) and maldescent of the
gonads (Figure 7M). Similar findings were obtained by
application of DHT propionate or testosterone (data
not shown).
In conclusion, our findings in mice lacking megalin
uncovered insensitivity to androgen and estrogen sig-
naling as well as distinct defects in fetal and postnatal
maturation of the reproductive organs. These pheno-
types are highly reminiscent of defects induced by anti-
androgens and anti-estrogens in rodents and strongly
implicate this receptor pathway for SHBG/ABP in sex-
steroid action in vivo.
Discussion
Until now, the identity and the role of proposed SHBG/
ABP receptors in steroid-hormone metabolism has re-
mained obscure. We show that megalin is an endocytic
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teceptor for SHBG/ABP in steroid target tissues that
ediates uptake of carrier bound androgens and estro-
ens. When exposed to sex steroids in the presence of
hysiological concentrations of carrier proteins, cells
re critically dependent on megalin activity to interna-
ize significant amounts of the hormones. Little uptake
s seen in the presence of megalin antagonists (Figure
C) or in keratinocytes that lack receptor expression
Figure 1F). Bound steroids are delivered to intracellular
ompartments (Figure 2A) and act as inducers of ste-
oid target genes, the hallmark of cellular steroid action
Figures 2B and 2C). Receptor interaction is solely de-
endent on the recognition of the carrier moiety by
egalin and is independent of the presence of the ste-
oid (Figure 1B). Although the exact route for internal-
zation and intracellular delivery of sex steroids is still
nclear, it likely involves vesicular pathways similar to
hose involved in endocytosis and intracellular traffick-
ng of vitamin D metabolites (Wu et al., 2000; Nykjaer
t al., 2001).
Among other work, experimental support for the free
ormone hypothesis was obtained by studies where
ptake of sex steroids was evaluated in cultured cells.
n these experiments, steroids entered cells when
dded in free form to the medium but were blocked
rom cellular entry in the presence of SHBG (Damassa
t al., 1991; Giorgi and Stein, 1981). These findings led
o the concept that only free steroids can access cells.
hus, many studies on the cellular metabolism of ste-
oid hormones were performed in the absence of carrier
roteins or using hormone derivatives that do not in-
eract with carriers. While these experimental condi-
ions are useful to investigate intracellular aspects of
teroid-hormone activity, they have drawn attention
way from the physiological context where, depending
n the steroid, as much as 95%–99.9% of the metabo-
ites are complexed to proteins (Dunn et al., 1981). Un-
er these conditions, free diffusion may be of quantita-
ively lesser importance for cellular delivery of steroids,
n particular in tissues that are in demand of large
mounts of steroid hormones. Contrary to the afore-
entioned studies, we demonstrate that cells are able
o internalize complexed sex steroids and to induce
teroid target genes, provided that they express the
HBG/ABP receptor megalin. Although megalin is
bundantly expressed in several absorptive epithelia
n vivo, few established cell lines express the receptor.
hus, this SHBG/ABP uptake pathway may have been
issed in previous studies using cells lacking the re-
eptor.
Evidence for a physiological role of megalin in sex-
teroid action stems from the defects observed in the
eceptor-deficient mouse model. Apart from bone dis-
ase as a consequence of hypovitaminosis D (Nykjaer
t al., 1999), adult megalin−/− animals suffer from ano-
alies in genital maturation consistent with insensitiv-
ty to androgens and estrogens. Despite normal (E2) or
ven increased levels (testosterone, DHT) of circulating
ormones, these mice exhibit defects seen in rodents
reated with anti-androgens and anti-estrogens. Thus,
emale receptor null mice fail to induce opening of the
agina cavity, a benchmark of natural puberty. This pro-
ess can be induced in the immature rodent by injec-
ion of E2 and blocked by application of anti-estrogens
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759Figure 7. Urogenital Tracts of E18.5 Embryos Treated with DHT In Utero
Mouse embryos were treated in utero with buffer (control) or DHT solution from E10.5 to E18.5 (see Experimental Procedures for details), and
the urogenital tracts of female (A–H) and male (I–Q) animals were studied by external inspection and histology at E18.5. A total of 8 to 20
animals were analyzed per group. In wild-type and megalin-deficient females, the ovaries (ov) are positioned laterally to the lower kidney pole
(A and B), with the CSL fixing the gonads to the abdominal body wall (arrows in [E] and [F]). When treated with DHT, the CSL in wild-type
females regresses (G), displacing the ovaries from the lower kidney pole (arrow in [C]). Megalin-deficient females exhibit marginally displaced
ovaries (arrows in [D] and [H]). In the male sex, the gonads are located near the bladder in wild-types (I and N) but are tethered through the
CSL to the abdominal body wall close to the kidneys in megalin knockouts (arrows in [K] and [O]). Similar findings can be seen in wild-type
(L and P) and megalin−/− embryos (M and Q) treated with exogenous DHT. bl, bladder; ep, epididymis; ki, kidney; ov, ovaries; te, testis.such as ICI 182,780 (Ashby et al., 2002). Presently, the
small number of megalin-deficient females available
(n = 18) precluded rigorously testing whether these
mice respond to exogenous E2 application. However,
in three such animals tested, injection of E2 did not
induce vagina opening.
Similar to females, megalin−/− males also exhibit de-
fects indicative of sex-steroid insensitivity, namely uni-
lateral testicular maldescent. This process can be in-
duced in offspring of pregnant rats and mice treated
with flutamide, an inhibitor of the AR, or with finasterite,
a blocker of 5α reductase that converts testosterone to
the more potent androgen DHT (Spencer et al., 1991).
Many hypotheses about the mechanisms of hormonally
controlled descent of the testes have been advanced,none of which have been proven definitively. This diffi-
culty is in part due to the mechanistical differences that
exist between humans, rodents, and other mammals in
this process. Common to all species is the pivotal role
of the CSL and the gubernaculum in determining posi-
tioning of the gonads in the body (Heyns and Hutson,
1995; Husmann and McPhaul, 1991; Spencer et al.,
1991). Much of the focus has been placed on the devel-
opment of the gubernaculum in males as it guides the
migrating testes through the inguinal canal into the
scrotum. Gene defects of several proteins, including
HOXA-10 (Rijli et al., 1995) or insulin-like hormone 3
(Nef and Parada, 1999; Zimmermann et al., 1999), that
impair development of the gubernaculum cause mal-
descendus testis. Recently, a role of hormonally regu-
Cell
760lated development of CSL also received major atten-
tion. Involution of the CSL in males is androgen
dependent, and, in mice lacking the AR (Hutson, 1986;
Zimmermann et al., 1999) or in animals treated with
anti-androgens (van der Schoot and Elger, 1992), the
CSL persists. Both bi- and unilateral testicular malde-
scent may be observed, highlighting the concept of
asymmetry in urogenital development (Lee and Hutson,
1999; van der Schoot and Elger, 1992). Unilateral testic-
ular maldescent as a consequence of persistence of
the CSL is a feature also shared by the megalin knock-
out mouse. Regression of the CSL cannot be induced
by exogenous application of high levels of free andro-
gens (Figure 7), strongly supporting the concept that
endocytic uptake of complexed steroids rather than
free diffusion of unbound steroids is required to speci-
fically deliver them to their target tissues.
Assuming a pivotal role of megalin in sex-steroid sig-
naling, it is intriguing to note that megalin null mice do
not share all of the anomalies seen in mice deficient for
the AR (e.g., testicular feminization) (Couse and Kor-
ach, 1998; Hutson, 1986) or estrogen receptors (ER)
(e.g., uterine hypoplasia) (Couse et al., 1999; Lubahn et
al., 1993). This observation suggests that megalin defi-
ciency impairs spatially and temporarily restricted
activities of androgens and estrogens in line with the
distinct expression pattern of the receptor during geni-
tal development. In particular, activities that require
apoptotic processes induced by paracrine action of
steroid hormones may involve this receptor pathway.
Thus, the exact molecular mechanism causing E2-
induced opening of the vagina cavity is unclear at pre-
sent, but it involves paracrine processes through tis-
sues other than the vaginal epithelium itself. This
hypothesis is based on the finding that blocking apo-
ptosis in mice by overexpression of Bcl2 in epithelial
and subepithelial cells of the vaginal mucosa results in
vaginal obstruction, whereas Bcl2 expression in epithe-
lial cells alone is insufficient (Rodriguez et al., 1997).
Similarly, local paracrine processes are also responsi-
ble for regulation of testicular descent. Although andro-
gens play a causal role in this process, the hormones
likely do not act on the CSL directly, as this tissue does
not express detectable levels of AR (Emmen et al.,
1998; Hutson et al., 1994). Instead, androgens are be-
lieved to act on neighboring cell types (e.g., primordium
of the CSL) that release paracrine factors such as epi-
dermal growth factor, which has been shown to amelio-
rate the effects of flutamide application on descent of
the testis (Cain et al., 1994). The concept of paracrine
action of steroids during testicular descent and vagina
opening may explain why expression of megalin is seen
not in the cell types that undergo apoptosis (CSL, vagi-
nal epithelium) but in adjacent tissues such as meso-
nephric tubules and uterine epithelium (Figures 3C
and 6B).
As well as acting in a locally restricted manner, ste-
roid-induced opening of the vagina cavity and testicular
descent are developmental processes that are induced
during a very narrow time window in development, war-
ranting the need for efficient steroid-uptake processes.
This is best exemplified by the application of DHT ana-
logs in pregnant rats to induce aberrant regression of
the CSL in female embryos. In this model, involution of
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ahe CSL is seen when steroids are applied before E17
ut not when they are applied at later embryonic stages
Emmen et al., 1998). Because AR expression in rats
tarts around E16.5, this leaves a narrow time window
or androgen action on the CSL. Similarly, application of
lutamide showed maximal effect on testicular descent
nly when applied between E16 and E17 (Husmann and
cPhaul, 1991), a time when the AR is expressed in the
esenchymal and epithelial cells of the mesonephric
ubules (where megalin is also seen).
In conclusion, our studies have uncovered endocytic
athways for cell-type-specific uptake of protein bound
ndrogens and estrogens that are required for steroid-
ependent maturation of the reproductive organs. Our
indings provide a novel paradigm for a biological role
f carrier bound steroids in hormone action that may
hange current concepts in steroid-hormone biology.
xperimental Procedures
aterials
is6-tagged human SHBG, His6-tagged murine and rat ABP, and
ST-tagged rat RAP were purified from HEK293 EBNA cells (Hilpert
t al., 2001) or bacteria (Nykjaer et al., 1999). Tritiated testosterone
TRK921), dihydrotestosterone (DHT) (TRK443), and 17β-estradiol
TRK322) were purchased from Amersham Pharmacia. FITC-labeled
α-aminohexyl-17β-hydroxy-5α-androstan-3-one (FITC-DHT) was
ynthesized as published (Metzger et al., 2003).
nimals
he generation of mice with megalin gene inactivation has been re-
orted before (Willnow et al., 1996). The line was kept by breeding of
nimals heterozygous for the receptor-gene defect (megalin+/−).
tudies were performed in megalin-deficient mice and their control
ittermates. The estrus cycle of the animals was predicted based
n the composition of vaginal smears (Vianney, 1965) or the his-
ological appearance of the mucous membranes formed by the va-
inal epithelium (Krinke, 2004; Yuan and Carlson, 1987). For appli-
ation of exogenous androgens, pregnant mice were injected
ubcutaneously with a daily dose of 2 mg of DHT (Sigma, Tauf-
irchen, Germany), DHT propionate (Steraloids, Newport, Rhode Is-
and), or testosterone (Sigma) in 20 l EtOH/180 l sunflower oil
rom day 10.5 to 18.5 postcoitum of pregnancy (or with EtOH/oil
nly as control), and the embryos were removed for analysis at
18.5.
mmunohistological Analysis
rogenital tracts from embryos, neonates, or adult mice were dis-
ected, fixed overnight in 4% paraformaldehyde in PBS at 4°C, and
mbedded in paraffin. Routine paraffin sections were cut at 5 m
hickness and stained with hematoxylin and eosin. For megalin de-
ection, unstained sections were incubated with sheep anti-mega-
in IgG (1:50,000) followed by peroxidase-conjugated rabbit anti-
heep antibody (1:100; Dako, Hamburg, Germany) and detection
ith diaminobenzidine.
ndocrine Analysis
estosterone, DHT, and 17β-estradiol levels in adult plasma sam-
les or E14.5 whole-embryo homogenates were determined using
pecific RIA (ICN Pharmaceuticals, Costa Mesa, California) or
LISA (for DHT; IBL, Hamburg, Germany) according to the manu-
acturers’ recommendations following tissue extraction of the ste-
oids by methanol and solid-phase extraction procedures (Nykjaer
t al., 1999).
ene-Expression Profiling
ene-expression profiling was performed on pools of total RNA
xtracted from the gonads of five wild-type and five megalin-defi-
ient E14.5 male embryos using the Mouse Genome 430 2.0 probe
rray (Affymetrix) according to the manufacturer’s protocols. For
Endocytic Pathways for Sex Steroids
761array-to-array comparison, the readings were scaled to a global
intensity of 200 (GCos v1.2). The readings from the quantitative
scanning were analyzed by the Affymetrix Gene Expression Analy-
sis Software (DMT v3.0).
Cell Binding and Uptake Studies
Surface plasmon resonance analysis of recombinant human SHBG
binding to megalin was performed according to standard protocols
(Nykjaer et al., 1999). Cell uptake and lysosomal degradation of
125I-labeled carrier proteins was determined as described (Nykjaer
et al., 2001). For preformation of complexes, purified carrier and
sex steroids were mixed in DMEM and incubated for 1 hr at room
temperature prior to isolation of complexes over PD-10 columns
(Amersham Pharmacia). Alternatively, complex formation was
achieved by adding recombinant SHBG and steroids at a molar
ratio of 10:1 to the cell medium. Cellular uptake of labeled steroids
or SHBG was determined as cell-associated radioactivity present
after washing of the cells with PBS and was expressed as percen-
tage of the total amount of radioactivity added. For detection of
DHT uptake, 1 M of SHBG and 5 M of FITC-DHT were incubated
overnight at 4°C in DMEM containing 0.1% ovalbumin (binding
buffer) and subsequently dialyzed against DMEM for 2 hr. BN16
cells were preincubated for 2 hr in DMEM prior to addition of 800
nM FITC-DHT/SHBG complexes in the presence or absence of 4
M RAP in binding buffer. After incubation for 90 min at 37°C, the
cells were washed, fixed in 4% paraformaldehyde, permeabilized
in 0.1% Triton X-100, and incubated with rabbit anti-SHBG IgG
(1:400) and anti-rabbit Alexa 660 IgG (Molecular Probes, Europe
BV). Uptake of SHBG and FITC-DHT was evaluated by confocal
fluorescence microscopy.
Cell Signaling Studies
A reporter plasmid was constructed containing expression cas-
settes for the human AR driven by the CMV promoter and the lucif-
erase gene controlled by the androgen-responsive MMTV promoter
(provided by A. Brinkmann, Erasmus University). Because BN16
cells are notoriously difficult to transfect, biolistic procedures were
used to transiently introduce the reporter construct (Bio-Rad Biolis-
tic PDS-1000/He device; Bio-Rad, Sundbyberg, Sweden). Transfec-
tion efficiencies of approximately 1% were achieved. Eighteen
hours posttransfection, the cells were incubated in DMEM, 0.1%
ovalbumin in the presence of 1 nM DHT, conditioned media from
HEK293 cells producing SHBG, SHBG media plus 1 nM DHT, or
SHBG media plus 1 nM DHT plus 5 M RAP. After 16 hr incubation,
cells were washed, and cell lysates were generated using Reporter
Lysis Buffer (Luciferase Assay System; Promega, Madison, Wis-
consin). Twenty microliters of lysate was added to 100 l of Lucifer-
ase Assay Reagent and quantified by luminometry. Determinations
were performed in triplicate, and luciferase activity was expressed
as total activity subtracted by the value for control incubation with-
out DHT (approximately 150 cpm).
Supplemental Data
Supplemental Data include four figures and one table and can be
found with this article online at http://www.cell.com/cgi/content/
full/122/5/751/DC1/.
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